Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Leukemia, Myeloid, Acute D015470 19 associated lipids
Ear Diseases D004427 7 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Agranulocytosis D000380 7 associated lipids
Shock D012769 11 associated lipids
Polycythemia Vera D011087 13 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Yamazaki H [Recent medical topics on platelets in hemorrhagic and thrombotic diseases]. 1986 Nippon Naika Gakkai Zasshi pmid:3027214
Prunieras M Melanocytes, melanogenesis, and inflammation. 1986 Int. J. Dermatol. pmid:2433237
Rink TJ Stimulus-response coupling mechanisms in human platelets. 1986 Agents Actions Suppl. pmid:3028101
Baroggi N et al. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. 1986 Agents Actions Suppl. pmid:3028108
Ozaki Y et al. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. 1986 Biochem. Pharmacol. pmid:3021173
Okamoto M et al. FR-900452, a specific antagonist of platelet activating factor (PAF) produced by Streptomyces phaeofaciens. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. 1986 J. Antibiot. pmid:3082838
Vanhoutte PM et al. Modulation of vascular smooth muscle contraction by the endothelium. 1986 Annu. Rev. Physiol. pmid:2871807
Camussi G Potential role of platelet-activating factor in renal pathophysiology. 1986 Kidney Int. pmid:3517457
Mastacchi R et al. Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. 1986 Agents Actions pmid:3518359
Simmet T and Peskar BA Eicosanoids and the coronary circulation. 1986 Rev. Physiol. Biochem. Pharmacol. pmid:3520775
Moudgil GC Anaesthesia and allergic drug reactions. 1986 Can Anaesth Soc J pmid:3521800
Foegh ML et al. Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. 1986 Transplantation pmid:3523888
Rampart M and Williams TJ Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. 1986 Am. J. Pathol. pmid:3524253
Zanetti A et al. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine. 1986 Eur. J. Pharmacol. pmid:2944757
Bush LR and Smith SG Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists. 1986 Thromb. Res. pmid:2948294
Braquet P Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. 1986 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2949548
Kloprogge E et al. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy. 1986 Biochem. J. pmid:3800968
Panchenko EP et al. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin]. 1986 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:3801147
Chamone DF et al. Increased levels of eosinophil-derived PAF-acether activity in a patient with idiopathic hypereosinophilic syndrome. 1986 Braz. J. Med. Biol. Res. pmid:3801724
Toth PD and Mikulaschek AW Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. 1986 Circ. Shock pmid:3802423
O'Flaherty JT et al. Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative. 1986 J. Immunol. pmid:3095426
Weber N [A platelet-activating factor--a physiologically active ether lipid]. 1986 Pharm Unserer Zeit pmid:3749211
Berti F et al. Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivatives. 1986 Pharmacol Res Commun pmid:3749244
Burhop KE et al. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites. 1986 Am. Rev. Respir. Dis. pmid:3752711
Hemmendinger S et al. [Methods of studying platelet function. Biological markers of the activation of human platelets in vivo and in vitro]. 1986 Ann. Biol. Clin. (Paris) pmid:3538949
Roubin R et al. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity. 1986 J. Immunol. pmid:3950403
Adnot S et al. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. 1986 Prostaglandins pmid:3562865
Malavasi F et al. Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3085094
Simpson AW et al. Low concentrations of the stable prostaglandin endoperoxide U44069 stimulate shape change in quin2-loaded platelets without a measurable increase in [Ca2+]i. 1986 FEBS Lett. pmid:3086128
Nakaya H and Tohse N Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine. 1986 Br. J. Pharmacol. pmid:3814909
Schlondorff D et al. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. 1986 Am. J. Physiol. pmid:3087218
Coëffier E et al. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs. 1986 Eur. J. Pharmacol. pmid:3816952
Oda M et al. Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide. 1986 J. Biochem. pmid:3818574
Nishihira J and Ishibashi T A phospholipase C with a high specificity for platelet-activating factor in rabbit liver light mitochondria. 1986 Lipids pmid:3821393
Lauri D et al. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. 1986 Agents Actions pmid:3706054
Nijssen JG et al. Identification of a calcium-independent phospholipase A2 in rat lung cytosol and differentiation from acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF-acether). 1986 Biochim. Biophys. Acta pmid:3707986
Fitzgerald MF et al. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs. 1986 Br. J. Pharmacol. pmid:3708213
Alloatti G et al. Effect of platelet-activating factor (PAF) on human cardiac muscle. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3941007
Chand N et al. The amplifier role of platelet activating factor (PAF), other chemical mediators and antigen in the induction of airway hyperreactivity to cold. 1986 Eur. J. Pharmacol. pmid:3709669
Lynch JM and Henson PM The intracellular retention of newly synthesized platelet-activating factor. 1986 J. Immunol. pmid:3093579
Osborne JA et al. In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit. 1986 Res. Commun. Chem. Pathol. Pharmacol. pmid:3715198
McMurtry IF and Morris KG Platelet-activating factor causes pulmonary vasodilation in the rat. 1986 Am. Rev. Respir. Dis. pmid:3094417
Issekutz AC and Ripley M The effect of intravascular neutrophil chemotactic factors on blood neutrophil and platelet kinetics. 1986 Am. J. Hematol. pmid:2934975
Alexandre A et al. Inhibition by antioxidants of agonist evoked cytosolic Ca++ increase, ATP secretion and aggregation of aspirinated human platelets. 1986 Biochem. Biophys. Res. Commun. pmid:3094518
Alam I and Silver MJ Acetyltransferase activity in human platelet microsomes and washed platelets. 1986 Biochim. Biophys. Acta pmid:3094588
Benhamou M et al. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone. 1986 J. Immunol. pmid:2935578
D'Humières S et al. PAF-acether-induced synthesis of prostacyclin by human endothelial cells. 1986 Eur. J. Pharmacol. pmid:3102256
Chung KF et al. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. 1986 J. Pharmacol. Exp. Ther. pmid:3005546
Morley J Platelet activating factor and asthma. 1986 Agents Actions pmid:3099555
Orchard MA et al. Basophil histamine release induced by a substance from stimulated human platelets. 1986 J. Immunol. pmid:2419428
Tselepis A et al. Effects of AGEPC on the intracellular levels of ions in Tetrahymena pyriformis. 1986 Biochem. Int. pmid:3099798
Schlondorff D et al. Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells. 1986 Biochem. Biophys. Res. Commun. pmid:3099783
Okayasu T et al. Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase. 1986 Biochim. Biophys. Acta pmid:3947669
Kloprogge E et al. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets. 1986 J. Biol. Chem. pmid:3015954
O'Flaherty JT et al. Binding and metabolism of platelet-activating factor by human neutrophils. 1986 J. Clin. Invest. pmid:3016027
Hanahan DJ Platelet activating factor: a biologically active phosphoglyceride. 1986 Annu. Rev. Biochem. pmid:3017194
Bette-Bobillo P et al. Interaction between blood components and a spin-labeled analogue of PAF-acether. 1986 Biochim. Biophys. Acta pmid:3017416
Levesque JP et al. Fibrinogen mitogenic effect on hemopoietic cell lines: control via receptor modulation. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3018735
Bachelet M et al. Changes induced by PAF-acether in diacyl and ether phospholipids from guinea-pig alveolar macrophages. 1986 Biochim. Biophys. Acta pmid:3092866
Alonso F et al. A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. 1986 Biochim. Biophys. Acta pmid:3092867
Baranes J et al. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. 1986 Pharmacol Res Commun pmid:3763677
Cirino M et al. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. 1986 Prostaglandins pmid:3763941
Wallace JL and Whittle BJ Profile of gastrointestinal damage induced by platelet-activating factor. 1986 Prostaglandins pmid:3763942
Bourgain RH et al. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig. 1986 Prostaglandins pmid:3763943
Guinot P et al. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. 1986 Prostaglandins pmid:3763944
Scherf H et al. Hemodynamic effects of platelet activating factor in the dog kidney in vivo. 1986 Hypertension pmid:3744467
Schleimer RP et al. Characterization of inflammatory mediator release from purified human lung mast cells. 1986 Am. Rev. Respir. Dis. pmid:3485946
Okamoto M et al. Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis(methylthio)gliotoxin and its derivatives. 1986 Chem. Pharm. Bull. pmid:2421923
Okamoto M et al. Studies of platelet activating factor (PAF) antagonists from microbial products. II. Pharmacological studies of FR-49175 in animal models. 1986 Chem. Pharm. Bull. pmid:2421924
Touvay C et al. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. 1986 Prog. Lipid Res. pmid:2827186
Herrmann DB et al. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. 1986 Biochim. Biophys. Acta pmid:3947667
Söling HD and Fest W Synthesis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in exocrine glands and its control by secretagogues. 1986 J. Biol. Chem. pmid:3095313
Ostermann G et al. The role of lipoproteins in the degradation of platelet-activating factor. 1986 Thromb. Res. pmid:3798402
Bussolino F et al. Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. 1986 Acta Haematol. pmid:3019063
Bussolino F et al. Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. 1986 Pharmacol Res Commun pmid:3490673
Jackson CV et al. Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine. 1986 Circ. Res. pmid:2868810
Bussolino F et al. Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. 1986 J. Clin. Invest. pmid:2872233
Henocq E and Vargaftig BB Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man. 1986 Lancet pmid:2872485
Wallace JL and Whittle BJ Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration. 1986 Br. J. Pharmacol. pmid:3096408
Ostermann G et al. Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. 1986 Thromb. Res. pmid:3764811
First International Alexis Carrel Conference on Lipid Mediators in Organ Transplantation. April 8-10, 1986, Washington, DC. 1986 Transplant. Proc. pmid:3765055
Satoh K and Takamatsu S [Inactivation by plasma of platelet-activating factor]. 1986 Nippon Ketsueki Gakkai Zasshi pmid:3766067
Kawaguchi H and Yasuda H Effect of platelet-activating factor on arachidonic acid metabolism in renal epithelial cells. 1986 Biochim. Biophys. Acta pmid:3081036
Gordeev KIu et al. [Synthesis of thioanalogs of platelet activating factor (PAF)]. 1986 Bioorg. Khim. pmid:3768051
Hoffman DR et al. Metabolism and function of platelet-activating factor in fetal rabbit lung development. 1986 Biochim. Biophys. Acta pmid:3768390
Okamoto M et al. Studies of platelet activating factor (PAF) antagonists from microbial products. III. Pharmacological studies of FR-900452 in animal models. 1986 Chem. Pharm. Bull. pmid:3769104
Ohga Y and Nakanishi M Stopped-flow spectrophotometry monitoring the initial processes of platelet activation by platelet-activating factor. 1986 FEBS Lett. pmid:3770190
Ramesha CS and Pickett WC Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes. 1986 J. Biol. Chem. pmid:3096991
Patterson R et al. Inhibition of rhesus monkey airway and cutaneous responses to platelet-activating factor (PAF) (AGEPC) with the anti-PAF agent SRI 63-072. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3770978
Newhouse MT and Sears MR Platelet activating factor, ketotifen and asthma. 1986 N. Z. Med. J. pmid:3462569
Smith PF et al. The responsiveness of rabbit bronchial rings to antigen, AGEPC and histamine. 1986 Immunopharmacology pmid:3771195
Chignard M et al. Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3464972
Kawaguchi H and Yasuda H Platelet-activating factor stimulates prostaglandin synthesis in cultured cells. 1986 Hypertension pmid:3081442
Andrikopoulos NK et al. High-performance liquid chromatographic analysis of platelet activating factor on a cation-exchange column by direct ultraviolet detection. 1986 J. Chromatogr. pmid:3771693
Hahn HL et al. Effects of platelet activating factor on tracheal mucus secretion, on airway mechanics and on circulating blood cells in live ferrets. 1986 Eur J Respir Dis Suppl pmid:3465554
Morley J and Sanjar S Ketotifen and asthma. 1986 N. Z. Med. J. pmid:3466080
Page CP Platelet activating factor, ketotifen and asthma. 1986 N. Z. Med. J. pmid:3466093
Etienne A et al. Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. 1986 Agents Actions Suppl. pmid:3468781
Zimmerman GA et al. Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. 1986 Ann. N. Y. Acad. Sci. pmid:3471149
Küster LJ and Frölich JC Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man. 1986 Prostaglandins pmid:3097760